Chemo-Free Regimen Boosts OS in Mesothelioma

(MedPage Today) -- A chemotherapy-free combination significantly improved overall survival (OS) as initial therapy for unresectable malignant pleural mesothelioma (MPM), a large randomized trial showed.
Patients treated with nivolumab (Opdivo...